Discontinued — last reported Q1 '19
Unrecognized tax benefits
Edwards Lifesciences Unrecognized tax benefits increased by 3.2% to $792.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.1%, from $700.10M to $792.10M. Over 5 years (FY 2020 to FY 2025), Unrecognized tax benefits shows an upward trend with a 22.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
A decrease suggests the resolution of tax audits or the expiration of statutes of limitations, while an increase suggests new tax positions with higher uncertainty.
Detailed definition
This represents the aggregate amount of tax benefits that have not been recognized in the financial statements because t...
Peer comparison
Peers generally maintain low levels of unrecognized tax benefits to minimize audit risk and financial statement volatility.
other_unrecognized_tax_benefitsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $318.70M | $340.80M | $358.40M | $379.90M | $398.50M | $418.30M | $475.30M | $496.80M | $520.00M | $542.90M | $583.90M | $608.80M | $619.10M | $656.50M | $678.80M | $700.10M | $722.10M | $746.90M | $767.40M | $792.10M |
| QoQ Change | — | +6.9% | +5.2% | +6.0% | +4.9% | +5.0% | +13.6% | +4.5% | +4.7% | +4.4% | +7.6% | +4.3% | +1.7% | +6.0% | +3.4% | +3.1% | +3.1% | +3.4% | +2.7% | +3.2% |
| YoY Change | — | — | — | — | +25.0% | +22.7% | +32.6% | +30.8% | +30.5% | +29.8% | +22.8% | +22.5% | +19.1% | +20.9% | +16.3% | +15.0% | +16.6% | +13.8% | +13.1% | +13.1% |
Unrecognized tax benefits at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's unrecognized tax benefits?
- Edwards Lifesciences (EW) reported unrecognized tax benefits of $792.10M in Q1 2026.
- How has Edwards Lifesciences's unrecognized tax benefits changed year-over-year?
- Edwards Lifesciences's unrecognized tax benefits increased by 13.1% year-over-year, from $700.10M to $792.10M.
- What is the long-term trend for Edwards Lifesciences's unrecognized tax benefits?
- Over 5 years (2020 to 2025), Edwards Lifesciences's unrecognized tax benefits has grown at a 22.2% compound annual growth rate (CAGR), from $281.80M to $767.40M.
- What does unrecognized tax benefits mean?
- The total value of tax savings the company has claimed or expects to claim but has not yet recorded due to uncertainty.